ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Identification of a prognostic index system and tumor immune infiltration characterization for lung adenocarcinoma based on mRNA molecular of pyroptosis

Li, Huawei; Chang, Xiaoyan; Wang, Haiyan; Peng, Bo; Wang, Jun; Zhang, Pengfei; Zhang, Linyou*哈尔滨医科大学
Frontiers in Medicine2022-9-15DOI: 10.3389/fmed.2022.934835
14阅读
引用收藏
分享

摘要

Background and purposePyroptosis is a form of programmed cell death, which plays an important role in tumorigenesis, progression, and regulation of the tumor microenvironment. It can affect lung adenocarcinoma (LUAD) progression. This study aimed to construct a pyroptosis-related mRNA prognostic index (PRMPI) for LUAD and clarify the tumor microenvironment infiltration characterization of LUAD. Materials and methodsWe performed a univariate Cox regression analysis for pyroptosis-related mRNAs in the TCGA cohort. Then, we used LASSO Cox regression to establish a PRMPI. The quantitative real time polymerase chain reaction (qRT-PCR) was used to quantify the relative expression of pyroptosis-related mRNAs. The CPTAC cohort was used to confirm the stability and wide applicability of the PRMPI. The single-sample gene set enrichment analysis (ssGSEA) was performed to assess the tumor microenvironment infiltration characterization. ResultsA total of 36 pyroptosis-related mRNAs were identified. The PRMPI was established based on five pyroptosis-related mRNAs. The expression patterns of these mRNAs were verified in LUAD samples from our medical center by qRT-PCR. High-PRMPI patients had worse overall survival than low-PRMPI patients. The result was validated in the CPTAC cohort. The comprehensive analysis indicated that the high-PRMPI patients exhibited lower immune activity, more aggressive immunophenotype, lower expression of immune checkpoint molecule, higher TP53 mutation rate, and higher tumor stemness than low-PRMPI patients. Low-PRMPI patients may be more sensitive to immunotherapy, while high-PRMPI patients may benefit more from chemotherapy and targeted therapy. ConclusionsThe PRMPI may be a promising biomarker to predict the prognosis, tumor microenvironment infiltration characterization, and the response to adjuvant therapy in LUAD.

学科与关键词

关键词
lung adenocarcinomapyroptosisimmunotherapyPRMPIOS
相关
加载中…
  • A novel defined pyroptosis-related gene signature predicts prognosis and correlates with the tumour immune microenvironment in lung adenocarcinoma
    Chen, Zi; Ge, Linyang; Xu, Shuanglan; Li, Qin*; Zhou, Linfu*Scientific Reports, 2023, 13(1): 9921.
  • A Pyroptosis-Related Signature Predicts Overall Survival and Immunotherapy Responses in Lung Adenocarcinoma
    Zhu, Kaibin; Yan, An; Zhou, Fucheng; Zhao, Su; Ning, Jinfeng; Yao, Lei; Shang, Desi; Chen, Lantao*Frontiers in Genetics, 2022, 13: 891301.被引 3
  • Necroptosis Identifies Novel Molecular Phenotypes and Influences Tumor Immune Microenvironment of Lung Adenocarcinoma
    Zhao, Chen*; Xiong, Kewei; Adam, Abdalla; Ji, Zhiqiang; Li, Xiangpan*Frontiers in Immunology, 2022, 13: 934494.被引 8
查看全部 →

发表信息

论文状态
公开发表
期刊
Frontiers in Medicine
发表日期
2022-09-15
卷期
第 9 卷
页码
934835
DOI
10.3389/fmed.2022.934835
期刊等级
3区
成果收录
SCIE
资助标注
Postgraduate Research & Practice Innovation Program of Harbin Medical University; [YJSCX2020-45HYD]

作者

  • L

    Li, Huawei (第一作者)

    2 · harbin med univ

  • C

    Chang, Xiaoyan

    2 · harbin med univ

查看全部 7 位作者收起作者
  • W

    Wang, Haiyan

  • P

    Peng, Bo

    2 · harbin med univ

  • W

    Wang, Jun

    2 · harbin med univ

  • Z

    Zhang, Pengfei

    2 · harbin med univ

  • Z

    Zhang, Linyou (通讯)

    2 · harbin med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417